Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms

Area of Science:

• Bone Biology
• Cell Signaling
• Biochemistry

Background:

• Nitric oxide (NO) is known to inhibit bone resorption.
• Inhibition of nitric oxide synthase (NOS) leads to increased bone resorption and decreased bone mineral density in vivo.
• The presence and specific isoforms of NOS in osteoclasts are not fully understood.

Purpose of the Study:

• To investigate the presence and roles of different nitric oxide synthase (NOS) isoforms in osteoclasts.
• To determine the effect of NO on osteoclast activity, replication, and bone resorption.
• To elucidate the regulatory mechanisms of NO in bone remodeling.

Main Methods:

• Immunocytochemistry and Northern blotting to detect NOS isoforms in rat and human osteoclast cell lines.
• Measurement of NADPH-diaphorase activity in osteoclasts.
• In vitro bone resorption assays using NOS inhibitors and NO donors.
• Assessment of osteoclast precursor replication.

Main Results:

• Both constitutive (cNOS) and inducible (iNOS) NOS isoforms are present in rat and human osteoclasts.
• iNOS expression is upregulated by IFN-gamma and LPS in rat osteoclasts.
• NO donors inhibit osteoclast precursor replication, while NOS inhibitors can enhance resorption in specific contexts.
• NO exerts a tonic inhibitory effect on osteoclast numbers and activity.

Conclusions:

• Nitric oxide (NO) plays a central role in regulating bone resorption by controlling osteoclast function and proliferation.
• The findings suggest a complex interplay between cNOS and iNOS in osteoclast activity.
• These results necessitate a revision of current understanding of calcium homeostasis and skeletal metabolism, with implications for human bone health.